Kinetic sells notes to pay for LifeCell:
This article was originally published in Clinica
Executive Summary
Advanced woundcare company Kinetic Concepts said it plans to raise $600m through a sale of convertible senior notes to help fund its acquisition of biosurgery firm LifeCell. The two companies agreed to a $1.7bn all-cash deal earlier this month (see Clinica No 1301, p 2). San Antonio, Texas-based Kinetic also plans to use the proceeds from the note sale to pay off debt, for ongoing working capital and for other general corporate purposes of the combined company. The convertible notes are due to mature in 2015.
You may also be interested in...
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.
Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification
Sandoz argued against paying higher rebates for two of its drugs via the Centers for Medicare and Medicaid Services’ Medicaid drug rebate program in a US court six years after the suggestion was first made.